BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8980801)

  • 1. Successful bone marrow transplantation in a Chinese boy with Wiskott-Aldrich syndrome.
    Huang MT; Chou CC; Jou ST; Lin KH; Hsieh KH
    Asian Pac J Allergy Immunol; 1996 Jun; 14(1):57-63. PubMed ID: 8980801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haploidentical bone marrow transplantation in a pediatric patient with Wiskott-Aldrich syndrome. A case report.
    Pury S; López Orozco M; Pichichero G; Sasia LV; Morell D; Álvarez MS; Basquiera AL; Mas ME; Salvucci K
    Arch Argent Pediatr; 2024 Feb; 122(1):e202310061. PubMed ID: 37471507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center.
    Ozsahin H; Le Deist F; Benkerrou M; Cavazzana-Calvo M; Gomez L; Griscelli C; Blanche S; Fischer A
    J Pediatr; 1996 Aug; 129(2):238-44. PubMed ID: 8765621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early bone marrow transplantation in an infant with Wiskott-Aldrich syndrome.
    Beard LJ; Toogood IR; Pearson CC; Ferrante A
    Am J Pediatr Hematol Oncol; 1991; 13(3):310-4. PubMed ID: 1793157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation in the Wiskott-Aldrich syndrome. Complete hematological and immunological reconstitution.
    Ochs HD; Lum LG; Johnson FL; Schiffman G; Wedgwood RJ; Storb R
    Transplantation; 1982 Nov; 34(5):284-8. PubMed ID: 6760485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of non-Hodgkin's lymphoma using R-CHOP in a patient with Wiskott-Aldrich syndrome followed by a reduced-intensity stem cell transplant.
    Koga Y; Takada H; Suminoe A; Ohga S; Hara T
    Pediatr Transplant; 2014 Sep; 18(6):E208-11. PubMed ID: 24930759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide.
    Kapoor N; Kirkpatrick D; Blaese RM; Oleske J; Hilgartner MH; Chaganti RS; Good RA; O'Reilly RJ
    Blood; 1981 Apr; 57(4):692-6. PubMed ID: 7008865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated donor BMT for Wiskott-Aldrich syndrome.
    Lenarsky C; Weinberg K; Kohn DB; Parkman R
    Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of the Wiskott-Aldrich syndrome by a graft of allogeneic bone marrow].
    Fischer A; Durandy A; Bordigoni P; Virelizier JL; Vilmer E; Arnaud-Battandier F; Lagrue A; Olive D; Griscelli C
    Arch Fr Pediatr; 1984 Nov; 41(9):611-6. PubMed ID: 6391414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful unmanipulated haploidentical bone marrow transplantation from an HLA 2-locus-mismatched mother for Wiskott-Aldrich syndrome after unrelated cord blood stem cell transplantation.
    Inagaki J; Park YD; Kishimoto T; Yoshioka A
    J Pediatr Hematol Oncol; 2005 Apr; 27(4):229-31. PubMed ID: 15838398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet function after allogeneic bone marrow transplantation in Wiskott-Aldrich syndrome].
    Megido M; Cesar JM; Maldonado MS; Otheo E; Muñoz A; Navarro JL
    Sangre (Barc); 1993 Jun; 38(3):233-4. PubMed ID: 8211550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant conditioning with busulfan (Myleran) and cyclophosphamide for nonmalignant diseases. Assessment of engraftment following histocompatible allogeneic bone marrow transplantation.
    Blazar BR; Ramsay NK; Kersey JH; Krivit W; Arthur DC; Filipovich AH
    Transplantation; 1985 Jun; 39(6):597-603. PubMed ID: 3890287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
    Parkman R; Rappeport J; Geha R; Belli J; Cassady R; Levey R; Nathan DG; Rosen FS
    N Engl J Med; 1978 Apr; 298(17):921-7. PubMed ID: 347289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival after bone marrow transplantation: a 15-year follow-up report of a patient with Wiskott-Aldrich syndrome.
    Meuwissen HJ; Bortin MM; Bach FH; Porter IH; Schreinmachers D; Harrison BA; Taft E
    J Pediatr; 1984 Sep; 105(3):365-9. PubMed ID: 6381679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful unrelated cord blood transplantation in an infant with Wiskott-Aldrich syndrome following recurrent cytomegalovirus disease.
    Kaneko M; Watanabe T; Watanabe H; Kimura M; Suzuya H; Okamoto Y; Nakagawa R; Kuroda Y
    Int J Hematol; 2003 Dec; 78(5):457-60. PubMed ID: 14704041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrelated bone marrow transplantation with a reduced toxicity myeloablative conditioning regimen in Wiskott-Aldrich syndrome.
    Kang HJ; Shin HY; Ko SH; Park JA; Kim EK; Rhim JW; Kim JG; Ahn HS
    J Korean Med Sci; 2008 Feb; 23(1):146-8. PubMed ID: 18303217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.
    Filipovich AH; Stone JV; Tomany SC; Ireland M; Kollman C; Pelz CJ; Casper JT; Cowan MJ; Edwards JR; Fasth A; Gale RP; Junker A; Kamani NR; Loechelt BJ; Pietryga DW; Ringdén O; Vowels M; Hegland J; Williams AV; Klein JP; Sobocinski KA; Rowlings PA; Horowitz MM
    Blood; 2001 Mar; 97(6):1598-603. PubMed ID: 11238097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful treatment of a patient with Wiskott-Aldrich syndrome using hematopoietic stem cell transplantation--case report and literature review].
    Yu J; Guan XM; Dai BT; Jiang LP; Su YC; Xiao JW; Liu XM; Xian Y; Xu YH; Yang XQ; Zhao XD
    Zhonghua Er Ke Za Zhi; 2009 Mar; 47(3):183-8. PubMed ID: 19573431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable mixed chimerism after hematopoietic stem cell transplantation in Wiskott-Aldrich syndrome.
    Doğu F; Kurtuluş-Ulküer M; Bilge Y; Bozdoğan G; Ulküer U; Malhatun E; Ikincioğullari A; Babacan E
    Pediatr Transplant; 2006 May; 10(3):395-9. PubMed ID: 16677369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.